Who
Robert James Rudelius
Director
Company insider
Files Form 4 as: Chief Financial Officer, PetVivo Holdings; Director, Axogen; Director, ProUroCare Medical.
In numbers
- Trades disclosed
- 155
- Buys
- 8
- Sells
- 1
- Bought
- $50K
- Sold
- $291K
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 12 Jun 2007
- Last trade
- 18 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 21 Sep 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $1,4402,000 at $0.72 | filing |
| 18 Sep 2026filed 21 Sep 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $1,1231,497 at $0.75 | filing |
| 18 Sep 2026filed 21 Sep 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $1,4402,000 at $0.72 | filing |
| 18 Sep 2026filed 21 Sep 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $1,1231,497 at $0.75 | filing |
| 15 Apr 2026filed 17 Apr 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $20K50,000 at $0.40 | filing |
| 15 Apr 2026filed 17 Apr 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $20K50,000 at $0.40 | filing |
| 9 Mar 2026filed 23 Mar 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $26K35,000 at $0.74 | filing |
| 9 Mar 2026filed 23 Mar 2026 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $26K35,000 at $0.74 | filing |
| 24 Nov 2025filed 25 Nov 2025 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $3,2403,000 at $1.08 | filing |
| 24 Nov 2025filed 25 Nov 2025 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $549523 at $1.05 | filing |
| 24 Nov 2025filed 25 Nov 2025 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $640500 at $1.28 | filing |
| 10 Oct 2025filed 17 Oct 2025 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $16K12,500 at $1.28 | filing |
| 31 Mar 2025filed 11 Aug 2025 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $9,35315,589 at $0.60 | filing |
| 30 Oct 2024filed 25 Nov 2024 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | $50K100,000 at $0.50 | filing |
| 16 Oct 2024filed 18 Nov 2024 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | —35,000 | filing |
| 16 Oct 2024filed 18 Oct 2024 | PetVivo HoldingsMedical Devices | SEC FORM 4 Code A | —35,000 | filing |
| 29 Dec 2023filed 2 Jan 2024 | PetVivo Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —31,780 at $0.00 | filing |
| 21 Nov 2022filed 22 Nov 2022 | PetVivo HoldingsMedical Devices | SEC FORM 4 Bought | $2,279860 at $2.65 | filing |
| 18 Nov 2022filed 21 Nov 2022 | PetVivo HoldingsMedical Devices | SEC FORM 4 Bought | $3,1621,240 at $2.55 | filing |
| 18 Nov 2022filed 21 Nov 2022 | PetVivo HoldingsMedical Devices | SEC FORM 4 Bought | $1,040400 at $2.60 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Robert James Rudelius; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.